Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elliot Israel

Showing results (71-80 of 322) with videos related to

Pageof 33
Sort By:
Respiratory Research|June 10, 2010
Corticosteroid suppression of lipoxin A4 and leukotriene B4 from alveolar macrophages in severe asthmaPankaj K Bhavsar, Bruce D Levy, Mark J Hew, et al.
The Lancet. Respiratory Medicine|January 28, 2014
Effect of ADRB2 polymorphisms on the efficacy of salmeterol and tiotropium in preventing COPD exacerbations: a prespecified substudy of the POET-COPD trialKlaus F Rabe, Leonardo M Fabbri, Elliot Israel, et al.
Allergy|March 10, 2020
Eosinophil-derived neurotoxin and clinical outcomes with mepolizumab in severe eosinophilic asthmaPeter Howarth, Santiago Quirce, Alberto Papi, et al.
Advances in Therapy|September 18, 2023
Effect of Tezepelumab on Lung Function in Patients With Severe, Uncontrolled Asthma in the Phase 3 NAVIGATOR StudyAndrew Menzies-Gow, Christopher S Ambrose, Gene Colice, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|June 10, 2020
Fungal sensitization and its relationship to mepolizumab response in patients with severe eosinophilic asthmaAndrew Wardlaw, Peter H Howarth, Elliot Israel, et al.
The Journal of Allergy and Clinical Immunology. in Practice|May 14, 2023
A Discrete Choice Experiment to Assess Patient Preferences for Asthma Rescue Therapy and Disease ManagementElliot Israel, Nabeel Farooqui, Chris Gillette, et al.
Journal of Personalized Medicine|April 3, 2021
Systems Approaches to Treatment Response to Imatinib in Severe Asthma: A Pilot StudySeung Han Baek, Dinah Foer, Katherine N Cahill, et al.
The Journal of Allergy and Clinical Immunology|April 24, 2013
Exhaled breath condensate eicosanoid levels associate with asthma and its severityShamsah Kazani, Anna Planaguma, Emiko Ono, et al.
Science Translational Medicine|March 1, 2013
Lipoxin A4 regulates natural killer cell and type 2 innate lymphoid cell activation in asthmaCindy Barnig, Manuela Cernadas, Stefanie Dutile, et al.
ERJ Open Research|November 26, 2024
Efficacy of tezepelumab in patients with severe asthma and persistent airflow obstructionElliot Israel, Mario Castro, Christopher S Ambrose, et al.
Pageof 33

Showing results (71-80 of 322) with videos related to

Sort By:
Pageof 33
Respiratory Research|June 10, 2010
Corticosteroid suppression of lipoxin A4 and leukotriene B4 from alveolar macrophages in severe asthmaPankaj K Bhavsar, Bruce D Levy, Mark J Hew, et al.
The Lancet. Respiratory Medicine|January 28, 2014
Effect of ADRB2 polymorphisms on the efficacy of salmeterol and tiotropium in preventing COPD exacerbations: a prespecified substudy of the POET-COPD trialKlaus F Rabe, Leonardo M Fabbri, Elliot Israel, et al.
Allergy|March 10, 2020
Eosinophil-derived neurotoxin and clinical outcomes with mepolizumab in severe eosinophilic asthmaPeter Howarth, Santiago Quirce, Alberto Papi, et al.
Advances in Therapy|September 18, 2023
Effect of Tezepelumab on Lung Function in Patients With Severe, Uncontrolled Asthma in the Phase 3 NAVIGATOR StudyAndrew Menzies-Gow, Christopher S Ambrose, Gene Colice, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|June 10, 2020
Fungal sensitization and its relationship to mepolizumab response in patients with severe eosinophilic asthmaAndrew Wardlaw, Peter H Howarth, Elliot Israel, et al.
The Journal of Allergy and Clinical Immunology. in Practice|May 14, 2023
A Discrete Choice Experiment to Assess Patient Preferences for Asthma Rescue Therapy and Disease ManagementElliot Israel, Nabeel Farooqui, Chris Gillette, et al.
Journal of Personalized Medicine|April 3, 2021
Systems Approaches to Treatment Response to Imatinib in Severe Asthma: A Pilot StudySeung Han Baek, Dinah Foer, Katherine N Cahill, et al.
The Journal of Allergy and Clinical Immunology|April 24, 2013
Exhaled breath condensate eicosanoid levels associate with asthma and its severityShamsah Kazani, Anna Planaguma, Emiko Ono, et al.
Science Translational Medicine|March 1, 2013
Lipoxin A4 regulates natural killer cell and type 2 innate lymphoid cell activation in asthmaCindy Barnig, Manuela Cernadas, Stefanie Dutile, et al.
ERJ Open Research|November 26, 2024
Efficacy of tezepelumab in patients with severe asthma and persistent airflow obstructionElliot Israel, Mario Castro, Christopher S Ambrose, et al.
Pageof 33